On May 19, Axios hosted an event discussing the unprecedented development of COVID-19 vaccines and the road ahead. Speakers included NIAID Director Dr. Anthony Fauci, Pfizer Chairman & CEO Dr. Albert Bourla and PhRMA President & CEO Stephen J. Ubl. View the event here:
America’s biopharmaceutical companies continue our work to end the pandemic and build a more resilient system. Learn more about these efforts at PhRMA.org/coronavirus.
Andrew Powaleny is Senior Director of Public Affairs at PhRMA and leads the organization's scientific communications. Before joining PhRMA in 2015, he worked in public affairs for a small firm in Washington, DC and served as Deputy Press Secretary for the House Committee on Energy and Commerce. Andrew came to Washington, D.C. via Connecticut with a degree from Eastern Connecticut State University where he majored in public policy and government. Andrew is active as a runner and volunteer with the DC Front Runners; most recently serving on its Board of Directors for three years as co-race director. He is also a member of the NLGJA: The Association of LGBTQ Journalists and mentors students through his alumni association with The Fund for American Studies. Andrew is passionate about scientific innovation, especially for mental illness, and his heroes are the men and women of America’s biopharmaceutical research companies.